Search or

𝛼SK

ENTITY

Medigen Vaccine Biologics (6547 TT)

1

Analysis

Health Care • Taiwan

Medigen Vaccine Biologics Corporation operates as a vaccination company. The Company develops flu vaccine, enterovirus vaccine, and other related products. Medigen Vaccine Biologics markets its products throughout worldwide.

more

Refresh

Exchange Announcement • 06 Nov 2025 19:16

Bod Approved Amendment To Fund Plan For 2022 Cash Increase & 1st Unsecured Cb.

Exchange Announcement • 06 Nov 2025 19:11

The Board Of Directors Resolved To Convene 2025 Extraordinary General Shareholders' Meeting.

Exchange Announcement • 06 Nov 2025 19:09

The Board Of Directors Has Resolved To Conduct A Cash Capital Increase Of Common Shares Through Private Placement.

Exchange Announcement • 06 Nov 2025 19:07

The Board Of Directors Has Resolved To Issue The Company’S 2nd Domestic Secured Convertible Bonds.

Exchange Announcement • 06 Nov 2025 19:06

The Board Of Directors Of The Company Has Resolved To Approve The Capital Expenditure Budget For Production Line Expansion And Additional Equipment Procurement.

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.9

x